$CCG
Cheche Group Inc. Stock $ccg

$ccg Overview Financials Valuation SEC Filings Company Website

2023 Q4 Form 20-F Financial Statement

#000121390024037229 Filed on April 29, 2024

Income Statement

Concept	2023 Q4	2023	2022 Q4
Revenue	$3.301B	3.301B cnies	$0.00
YoY Change
Cost Of Revenue	$3.161B	3.161B cnies
YoY Change		24.62%
Gross Profit	$140.2M	140.2M cnies
YoY Change		-1.47%
Gross Profit Margin	4.25%	4.25%
Selling, General & Admin	$250.8M	250.8M cnies	$930.0K
YoY Change	26871.94%	11512.92%	675.0%
% of Gross Profit	178.88%	178.88%
Research & Development	$57.17M	57.17M cnies
YoY Change		14.46%
% of Gross Profit	40.77%	40.77%
Depreciation & Amortization	$3.149M	1.000M cnies
YoY Change		-16.67%
% of Gross Profit	2.25%	0.71%
Operating Expenses	$308.0M	308.0M cnies	$930.0K
YoY Change	33018.92%	14159.54%	675.0%
Operating Profit	-$167.8M	-167.8M cnies
YoY Change		44.7%
Interest Expense	$1.406M	1.446M cnies	$660.0K
YoY Change	113.03%	-85.81%	-75.09%
% of Operating Profit
Other Income/Expense, Net	-$5.949M	-127.0K cnies	$450.0K
YoY Change	-1422.0%	-128.22%
Pretax Income	-$160.0M	-160.0M cnies	$190.0K
YoY Change	-84285.79%	-1986.24%	-92.49%
Income Tax	-$363.0K	-363.0K cnies
% Of Pretax Income
Net Earnings	-$921.8M	-159.6M cnies	$190.0K
YoY Change	-485236.32%	-1981.96%	-92.49%
Net Earnings / Revenue	-27.92%	-4.83%
Basic Earnings Per Share		-$20.30
Diluted Earnings Per Share	-$12.17	-$20.30	$0.01
COMMON SHARES
Basic Shares Outstanding		45.42M shares
Diluted Shares Outstanding		45.42M shares

Balance Sheet

Concept	2023 Q4	2023	2022 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$264.9M	$264.9M	$100.0K
YoY Change	264766.0%	264766.0%	-85.71%
Cash & Equivalents	243.4M cnies	$243.4M	114.9M cnies
Short-Term Investments	$21.47M	$21.47M
Other Short-Term Assets	$9.407M	$9.407M	$0.00
YoY Change			-100.0%
Inventory
Prepaid Expenses
Receivables	466.1M cnies	$466.1M	401.7M cnies
Other Receivables	$39.91M	$39.91M
Total Short-Term Assets	780.3M cnies	$780.3M	$100.0K
YoY Change	780153.0%	780153.0%	-87.5%
LONG-TERM ASSETS
Property, Plant & Equipment	1.667M cnies	$11.92M	2.171M cnies
YoY Change	-23.22%
Goodwill	84.61M cnies		84.61M cnies
YoY Change	0.0%
Intangibles	8.050M cnies		10.15M cnies
YoY Change	-20.69%
Long-Term Investments			$69.80M
YoY Change			-78.47%
Other Assets	4.149M cnies	$9.149M
YoY Change
Total Long-Term Assets	113.7M cnies	$113.7M	$69.80M
YoY Change	62.93%	62.93%	-78.47%
TOTAL ASSETS
Total Short-Term Assets	780.3M cnies	$780.3M	$100.0K
Total Long-Term Assets	113.7M cnies	$113.7M	$69.80M
Total Assets	894.0M cnies	$894.0M	$69.90M
YoY Change	1178.94%	1178.94%	-78.49%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	316.9M cnies	$316.9M	$800.0K
YoY Change	39508.5%	39508.5%	166.67%
Accrued Expenses	789.0K cnies	$78.44M	$1.300M
YoY Change	-39.31%	5934.15%	550.0%
Deferred Revenue	4.295M cnies		900.0K cnies
YoY Change	377.22%		-89.66%
Short-Term Debt	20.00M cnies	$20.00M	$1.500M
YoY Change	1233.33%	1233.33%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	501.5M cnies	$501.5M	$3.500M
YoY Change	14229.51%	14229.51%	600.0%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$12.25M	$12.25M	$300.0K
YoY Change	3983.0%	3983.0%	-98.52%
Total Long-Term Liabilities	14.26M cnies	$12.25M	$300.0K
YoY Change	4654.0%	3983.0%	-98.52%
TOTAL LIABILITIES
Total Short-Term Liabilities	501.5M cnies	$501.5M	$3.500M
Total Long-Term Liabilities	14.26M cnies	$12.25M	$300.0K
Total Liabilities	515.8M cnies	$515.8M	$3.800M
YoY Change	13473.55%	13473.55%	-81.73%
SHAREHOLDERS EQUITY
Retained Earnings	-2.114B cnies		-1.260B cnies
YoY Change	67.83%
Common Stock	5.000K cnies		2.000K cnies
YoY Change	150.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)	1.025M cnies		1.025M cnies
YoY Change	0.0%
Treasury Stock Shares
Shareholders Equity	378.2M cnies	$378.2M	$66.10M
YoY Change
Total Liabilities & Shareholders Equity	894.0M cnies	$894.0M	$69.90M
YoY Change	1178.94%	1178.94%	-78.49%

Cashflow Statement

Concept	2023 Q4	2023	2022 Q4
OPERATING ACTIVITIES
Net Income	-$921.8M	-159.6M cnies	$190.0K
YoY Change	-485236.32%	-1981.96%	-92.49%
Depreciation, Depletion And Amortization	$3.149M	1.000M cnies
YoY Change		-16.67%
Cash From Operating Activities	-$26.29M	-27.00M cnies	-$130.0K
YoY Change	20123.08%	4809.09%	225.0%
INVESTING ACTIVITIES
Capital Expenditures	$549.0K	549.0K cnies
YoY Change		-55.73%
Acquisitions
YoY Change
Other Investing Activities	-$7.669M	$13.37M	-$370.0K
YoY Change	1972.7%	-94.78%
Cash From Investing Activities	-$8.218M	12.82M cnies	-$370.0K
YoY Change	2121.08%	-94.99%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net		0.000 cnies	$0.00
YoY Change		-100.0%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	160.7M	140.3M cnies	370.0K
YoY Change	43341.89%	-154.82%
NET CHANGE
Cash From Operating Activities	-26.29M	-27.00M cnies	-130.0K
Cash From Investing Activities	-8.218M	12.82M cnies	-370.0K
Cash From Financing Activities	160.7M	140.3M cnies	370.0K
Net Change In Cash	126.2M	128.4M cnies	-130.0K
YoY Change	-97197.69%	-23454.0%	225.0%
FREE CASH FLOW
Cash From Operating Activities	-$26.29M	-27.00M cnies	-$130.0K
Capital Expenditures	$549.0K	549.0K cnies
Free Cash Flow	-$26.84M	-27.55M cnies
YoY Change		1439.05%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023	dei	Document Type DocumentType	20-F
CY2023	dei	Document Registration Statement DocumentRegistrationStatement	false
CY2023	dei	Document Annual Report DocumentAnnualReport	true
CY2023	dei	Document Period End Date DocumentPeriodEndDate	2023-12-31
CY2023	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023	dei	Document Transition Report DocumentTransitionReport	false
CY2023	dei	Document Shell Company Report DocumentShellCompanyReport	false
CY2023	dei	Entity File Number EntityFileNumber	001-41801
CY2023	dei	Entity Registrant Name EntityRegistrantName	Cheche Group Inc.
CY2023	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	E9
CY2023	dei	Entity Address Address Line1 EntityAddressAddressLine1	8/F, Desheng Hopson Fortune Plaza
CY2023	dei	Entity Address Address Line2 EntityAddressAddressLine2	13-1 Deshengmenwai Avenue
CY2023	dei	Entity Address City Or Town EntityAddressCityOrTown	Beijing
CY2023	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	100088
CY2023	dei	Entity Address Country EntityAddressCountry	CN
CY2023	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2023	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2023	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2023	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
CY2023	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2023	dei	Document Fin Stmt Error Correction Flag DocumentFinStmtErrorCorrectionFlag	true
CY2023	dei	Document Fin Stmt Restatement Recovery Analysis Flag DocumentFinStmtRestatementRecoveryAnalysisFlag	false
CY2023	dei	Document Accounting Standard DocumentAccountingStandard	U.S. GAAP
CY2023	dei	Entity Shell Company EntityShellCompany	false
CY2023	dei	Auditor Firm AuditorFirmId	1424
CY2023	dei	Auditor Name AuditorName	PricewaterhouseCoopers Zhong Tian LLP
CY2023	dei	Auditor Location AuditorLocation	Beijing, the People’s Republic of China
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	114945000	cny
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	243392000	cny
CY2022Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	5000000	cny
CY2022Q4	us-gaap	Short Term Investments ShortTermInvestments	34823000	cny
CY2023Q4	us-gaap	Short Term Investments ShortTermInvestments	21474000	cny
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	401667000	cny
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	466066000	cny
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	44412000	cny
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	49321000	cny
CY2022Q4	us-gaap	Assets Current AssetsCurrent	600847000	cny
CY2023Q4	us-gaap	Assets Current AssetsCurrent	780253000	cny
CY2023Q4	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	5000000	cny
CY2022Q4	us-gaap	Property Plant And Equipment Other Net PropertyPlantAndEquipmentOtherNet	2171000	cny
CY2023Q4	us-gaap	Property Plant And Equipment Other Net PropertyPlantAndEquipmentOtherNet	1667000	cny
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	10150000	cny
CY2023Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	8050000	cny
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	14723000	cny
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	10249000	cny
CY2022Q4	us-gaap	Goodwill Goodwill	84609000	cny
CY2023Q4	us-gaap	Goodwill Goodwill	84609000	cny
CY2023Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	4149000	cny
CY2022Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	111653000	cny
CY2023Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	113724000	cny
CY2022Q4	us-gaap	Assets Assets	712500000	cny
CY2023Q4	us-gaap	Assets Assets	893977000	cny
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	227156000	cny
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	316868000	cny
CY2023Q4	us-gaap	Short Term Borrowings ShortTermBorrowings	20000000	cny
CY2022Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	888000	cny
CY2023Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	4295000	cny
CY2022Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	63303000	cny
CY2023Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	73609000	cny
CY2022Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	3078000	cny
CY2023Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	950000	cny
CY2022Q4	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	40888000	cny
CY2023Q4	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	25759000	cny
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	7676000	cny
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	3951000	cny
CY2022Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	1045000	cny
CY2023Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	850000	cny
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	344034000	cny
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	501533000	cny
CY2022Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	2538000	cny
CY2023Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	2013000	cny
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	6226000	cny
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	5398000	cny
CY2022Q4	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	1432000	cny
CY2023Q4	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	1432000	cny
CY2023Q4	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	5419000	cny
CY2022Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	70128000	cny
CY2023Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	14262000	cny
CY2022Q4	us-gaap	Liabilities Liabilities	414162000	cny
CY2023Q4	us-gaap	Liabilities Liabilities	515795000	cny
CY2022Q4	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	1558881000	cny
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00001
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00001
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	5000000000	shares
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	5000000000	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	31780394	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	31780394	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	75440709	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	75440709	shares
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	2000	cny
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	5000	cny
CY2022Q4	us-gaap	Treasury Stock Value TreasuryStockValue	1025000	cny
CY2023Q4	us-gaap	Treasury Stock Value TreasuryStockValue	1025000	cny
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	25000	cny
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	2491873000	cny
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-1259479000	cny
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-2113821000	cny
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-66000	cny
CY2023Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	1150000	cny
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-1260543000	cny
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	378182000	cny
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	712500000	cny
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	893977000	cny
CY2021	us-gaap	Revenues Revenues	1735404000	cny
CY2022	us-gaap	Revenues Revenues	2679059000	cny
CY2023	us-gaap	Revenues Revenues	3301418000	cny
CY2021	us-gaap	Cost Of Revenue CostOfRevenue	1654592000	cny
CY2022	us-gaap	Cost Of Revenue CostOfRevenue	2536746000	cny
CY2023	us-gaap	Cost Of Revenue CostOfRevenue	3161193000	cny
CY2021	us-gaap	Gross Profit GrossProfit	80812000	cny
CY2022	us-gaap	Gross Profit GrossProfit	142313000	cny
CY2023	us-gaap	Gross Profit GrossProfit	140225000	cny
CY2021	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	110064000	cny
CY2022	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	138970000	cny
CY2023	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	111454000	cny
CY2021	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	79672000	cny
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	69350000	cny
CY2023	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	139385000	cny
CY2021	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	46785000	cny
CY2022	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	49946000	cny
CY2023	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	57167000	cny
CY2021	us-gaap	Operating Expenses OperatingExpenses	236521000	cny
CY2022	us-gaap	Operating Expenses OperatingExpenses	258266000	cny
CY2023	us-gaap	Operating Expenses OperatingExpenses	308006000	cny
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	-155709000	cny
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-115953000	cny
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	-167781000	cny
CY2021	us-gaap	Investment Income Interest InvestmentIncomeInterest	278000	cny
CY2022	us-gaap	Investment Income Interest InvestmentIncomeInterest	1890000	cny
CY2023	us-gaap	Investment Income Interest InvestmentIncomeInterest	5398000	cny
CY2021	us-gaap	Interest Expense InterestExpense	6522000	cny
CY2022	us-gaap	Interest Expense InterestExpense	3303000	cny
CY2023	us-gaap	Interest Expense InterestExpense	1446000	cny
CY2021	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	2100000	cny
CY2022	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	13409000	cny
CY2023	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-2546000	cny
CY2021	us-gaap	Interest Income Securities Us Treasury And Other Us Government InterestIncomeSecuritiesUSTreasuryAndOtherUSGovernment	24275000	cny
CY2022	us-gaap	Interest Income Securities Us Treasury And Other Us Government InterestIncomeSecuritiesUSTreasuryAndOtherUSGovernment	20314000	cny
CY2023	us-gaap	Interest Income Securities Us Treasury And Other Us Government InterestIncomeSecuritiesUSTreasuryAndOtherUSGovernment	12371000	cny
CY2021	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-153000	cny
CY2022	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	196000	cny
CY2023	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-1702000	cny
CY2021	us-gaap	Fair Value Option Changes In Fair Value Gain Loss1 FairValueOptionChangesInFairValueGainLoss1	-11242000	cny
CY2022	us-gaap	Fair Value Option Changes In Fair Value Gain Loss1 FairValueOptionChangesInFairValueGainLoss1	-6451000	cny
CY2023	us-gaap	Fair Value Option Changes In Fair Value Gain Loss1 FairValueOptionChangesInFairValueGainLoss1	-7524000	cny
CY2021	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-316000	cny
CY2022	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-1253000	cny
CY2023	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-127000	cny
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-146983000	cny
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-91543000	cny
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-159953000	cny
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-522000	cny
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-521000	cny
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-363000	cny
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-146461000	cny
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-91022000	cny
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-159590000	cny
CY2021	ccg	Accretions To Preferred Share Redemption Value AccretionsToPreferredShareRedemptionValue	-101467000	cny
CY2022	ccg	Accretions To Preferred Share Redemption Value AccretionsToPreferredShareRedemptionValue	188271000	cny
CY2023	ccg	Accretions To Preferred Share Redemption Value AccretionsToPreferredShareRedemptionValue	762169000	cny
CY2021	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-44994000	cny
CY2022	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-279293000	cny
CY2023	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-921759000	cny
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-146461000	cny
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-91022000	cny
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-159590000	cny
CY2021	us-gaap	Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax	10278000	cny
CY2022	us-gaap	Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax	-8207000	cny
CY2023	us-gaap	Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax	-1621000	cny
CY2021	us-gaap	Oci Market Risk Benefit Instrument Specific Credit Risk Gain Loss After Adjustments Before Tax Parent OciMarketRiskBenefitInstrumentSpecificCreditRiskGainLossAfterAdjustmentsBeforeTaxParent	1590000	cny
CY2022	us-gaap	Oci Market Risk Benefit Instrument Specific Credit Risk Gain Loss After Adjustments Before Tax Parent OciMarketRiskBenefitInstrumentSpecificCreditRiskGainLossAfterAdjustmentsBeforeTaxParent	-476000	cny
CY2023	us-gaap	Oci Market Risk Benefit Instrument Specific Credit Risk Gain Loss After Adjustments Before Tax Parent OciMarketRiskBenefitInstrumentSpecificCreditRiskGainLossAfterAdjustmentsBeforeTaxParent	-405000	cny
CY2021	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-8688000	cny
CY2022	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	7731000	cny
CY2023	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	1216000	cny
CY2021	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-155149000	cny
CY2022	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-83291000	cny
CY2023	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-158374000	cny
CY2021	us-gaap	Temporary Equity Accretion To Redemption Value Adjustment TemporaryEquityAccretionToRedemptionValueAdjustment	-101467000	cny
CY2022	us-gaap	Temporary Equity Accretion To Redemption Value Adjustment TemporaryEquityAccretionToRedemptionValueAdjustment	188271000	cny
CY2023	us-gaap	Temporary Equity Accretion To Redemption Value Adjustment TemporaryEquityAccretionToRedemptionValueAdjustment	762169000	cny
CY2021	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-53682000	cny
CY2022	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-271562000	cny
CY2023	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-920543000	cny
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.33
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-8.79
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-20.3
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.33
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-8.79
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-20.3
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	33831133	shares
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	31780394	shares
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	45415205	shares
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	33831133	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	31780394	shares
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	45415205	shares
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	18532000	cny
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	16208000	cny
CY2023	us-gaap	Share Based Compensation ShareBasedCompensation	109983000	cny
CY2021	ccg	Share Based Compensation Expenses Cost Of Revenues ShareBasedCompensationExpensesCostOfRevenues	8000	cny
CY2022	ccg	Share Based Compensation Expenses Cost Of Revenues ShareBasedCompensationExpensesCostOfRevenues	11000	cny
CY2023	ccg	Share Based Compensation Expenses Cost Of Revenues ShareBasedCompensationExpensesCostOfRevenues	191000	cny
CY2021	ccg	Share Based Compensation Expenses Selling And Marketing Expenses ShareBasedCompensationExpensesSellingAndMarketingExpenses	10692000	cny
CY2022	ccg	Share Based Compensation Expenses Selling And Marketing Expenses ShareBasedCompensationExpensesSellingAndMarketingExpenses	9124000	cny
CY2023	ccg	Share Based Compensation Expenses Selling And Marketing Expenses ShareBasedCompensationExpensesSellingAndMarketingExpenses	30688000	cny
CY2021	ccg	Share Based Compensation Expenses General And Administrative Expenses ShareBasedCompensationExpensesGeneralAndAdministrativeExpenses	7604000	cny
CY2022	ccg	Share Based Compensation Expenses General And Administrative Expenses ShareBasedCompensationExpensesGeneralAndAdministrativeExpenses	6668000	cny
CY2023	ccg	Share Based Compensation Expenses General And Administrative Expenses ShareBasedCompensationExpensesGeneralAndAdministrativeExpenses	67519000	cny
CY2021	ccg	Share Based Compensation Expenses Research And Development Expenses ShareBasedCompensationExpensesResearchAndDevelopmentExpenses	228000	cny
CY2022	ccg	Share Based Compensation Expenses Research And Development Expenses ShareBasedCompensationExpensesResearchAndDevelopmentExpenses	405000	cny
CY2023	ccg	Share Based Compensation Expenses Research And Development Expenses ShareBasedCompensationExpensesResearchAndDevelopmentExpenses	11585000	cny
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	-804571000	cny
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-146461000	cny
CY2021	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	18532000	cny
CY2021	us-gaap	Stock Redeemed Or Called During Period Value StockRedeemedOrCalledDuringPeriodValue	101467000	cny
CY2021	ccg	Redesignation From Ordinary Shares To Pre A Convertible Redeemable Preferred Shares RedesignationFromOrdinarySharesToPreAConvertibleRedeemablePreferredShares	165468000	cny
CY2021	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-10278000	cny
CY2021	ccg	Fair Value Changes Of Amounts Due To Related Party Due To Own Credit Risk FairValueChangesOfAmountsDueToRelatedPartyDueToOwnCreditRisk	1590000	cny
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	-1005189000	cny
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	-1005189000	cny
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-91022000	cny
CY2022	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	16208000	cny
CY2022	us-gaap	Stock Redeemed Or Called During Period Value StockRedeemedOrCalledDuringPeriodValue	-188271000	cny
CY2022	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	8207000	cny
CY2022	ccg	Fair Value Changes Of Amounts Due To Related Party Due To Own Credit Risk FairValueChangesOfAmountsDueToRelatedPartyDueToOwnCreditRisk	-476000	cny
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-1260543000	cny
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-1260543000	cny
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-159590000	cny
CY2023	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	109983000	cny
CY2023	us-gaap	Stock Redeemed Or Called During Period Value StockRedeemedOrCalledDuringPeriodValue	-762169000	cny
CY2023	us-gaap	Stock Issued During Period Value Conversion Of Units StockIssuedDuringPeriodValueConversionOfUnits	2321050000	cny
CY2023	ccg	Pipe Financing Prime Impact Cayman Ll Cthe Sponsor PIPEFinancingPrimeImpactCaymanLLCtheSponsor	8609000	cny
CY2023	ccg	Pipe Financing World Dynamic Limited PIPEFinancingWorldDynamicLimited	93436000	cny
CY2023	ccg	Pipe Financing Goldrock Holdings Limited PIPEFinancingGoldrockHoldingsLimited	35863000	cny
CY2023	ccg	Capitalization Of Pipe Financing Costs CapitalizationOfPIPEFinancingCosts	-4953000	cny
CY2023	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	-4720000	cny
CY2023	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	1621000	cny
CY2023	ccg	Fair Value Changes Of Amounts Due To Related Party Due To Own Credit Risk FairValueChangesOfAmountsDueToRelatedPartyDueToOwnCreditRisk	-405000	cny
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	378182000	cny
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-146461000	cny
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-91022000	cny
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-159590000	cny
CY2021	us-gaap	Depreciation Depreciation	1665000	cny
CY2022	us-gaap	Depreciation Depreciation	1162000	cny
CY2023	us-gaap	Depreciation Depreciation	1049000	cny
CY2021	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	10981000	cny
CY2022	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	8150000	cny
CY2023	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	8410000	cny
CY2021	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	2202000	cny
CY2022	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	2100000	cny
CY2023	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	2100000	cny
CY2021	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-153000	cny
CY2022	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	196000	cny
CY2023	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-1702000	cny
CY2021	us-gaap	Fair Value Option Changes In Fair Value Gain Loss1 FairValueOptionChangesInFairValueGainLoss1	-11242000	cny
CY2022	us-gaap	Fair Value Option Changes In Fair Value Gain Loss1 FairValueOptionChangesInFairValueGainLoss1	-6451000	cny
CY2023	us-gaap	Fair Value Option Changes In Fair Value Gain Loss1 FairValueOptionChangesInFairValueGainLoss1	-7524000	cny
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	18532000	cny
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	16208000	cny
CY2023	us-gaap	Share Based Compensation ShareBasedCompensation	109983000	cny
CY2021	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	484000	cny
CY2022	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	23000	cny
CY2023	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	1203000	cny
CY2021	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	2100000	cny
CY2022	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	13409000	cny
CY2023	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-2546000	cny
CY2021	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-16000	cny
CY2022	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-7000	cny
CY2023	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-46000	cny
CY2021	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-525000	cny
CY2022	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-525000	cny
CY2023	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-525000	cny
CY2021	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	164816000	cny
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	115954000	cny
CY2023	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	65602000	cny
CY2021	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	5960000	cny
CY2022	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	8725000	cny
CY2023	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	7028000	cny
CY2021	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	96386000	cny
CY2022	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	46857000	cny
CY2023	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	89712000	cny
CY2021	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	5423000	cny
CY2022	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-7818000	cny
CY2023	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	3407000	cny
CY2021	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	11444000	cny
CY2022	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	10951000	cny
CY2023	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	10306000	cny
CY2021	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	-140000	cny
CY2022	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	-1330000	cny
CY2023	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	-2128000	cny
CY2021	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	-16085000	cny
CY2022	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	-4251000	cny
CY2023	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	-17680000	cny
CY2021	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-10554000	cny
CY2022	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-8232000	cny
CY2023	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-8981000	cny
CY2021	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	825000	cny
CY2022	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	300000	cny
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-187594000	cny
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-158861000	cny
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-26950000	cny
CY2021	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1625000	cny
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1240000	cny
CY2023	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	549000	cny
CY2021	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	52000	cny
CY2023	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	22000	cny
CY2021	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments	63757000	cny
CY2022	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments	182474000	cny
CY2023	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments	42722000	cny
CY2022	us-gaap	Proceeds From Maturities Prepayments And Calls Of Shortterm Investments ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments	211408000	cny
CY2023	us-gaap	Proceeds From Maturities Prepayments And Calls Of Shortterm Investments ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments	56071000	cny
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-65330000	cny
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	27694000	cny
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	12822000	cny
CY2021	us-gaap	Proceeds From Other Short Term Debt ProceedsFromOtherShortTermDebt	10000000	cny
CY2022	us-gaap	Proceeds From Other Short Term Debt ProceedsFromOtherShortTermDebt	10000000	cny
CY2023	us-gaap	Proceeds From Other Short Term Debt ProceedsFromOtherShortTermDebt	20000000	cny
CY2021	us-gaap	Repayments Of Other Short Term Debt RepaymentsOfOtherShortTermDebt	20000000	cny
CY2022	us-gaap	Repayments Of Other Short Term Debt RepaymentsOfOtherShortTermDebt	20000000	cny
CY2021	us-gaap	Proceeds From Repayments Of Related Party Debt ProceedsFromRepaymentsOfRelatedPartyDebt	-20000000	cny
CY2021	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	19127000	cny
CY2021	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	7287000	cny
CY2022	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	11840000	cny
CY2021	ccg	Cash Repayments Of Amounts Due To A Related Party CashRepaymentsOfAmountsDueToARelatedParty	15000000	cny
CY2021	ccg	Cash Repayments Of Amounts Due To A Related Party Note20aii CashRepaymentsOfAmountsDueToARelatedPartyNote20aii	6328000	cny
CY2023	ccg	Cash Repayments Of Amounts Due To A Related Party Note20aii CashRepaymentsOfAmountsDueToARelatedPartyNote20aii	12610000	cny
CY2023	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	4953000	cny
CY2021	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	175979000	cny
CY2021	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	-206064000	cny
CY2022	us-gaap	Proceeds From Issuance Of Preferred Stock And Preference Stock ProceedsFromIssuanceOfPreferredStockAndPreferenceStock	-137202000	cny
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	583674000	cny
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-159042000	cny
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	140345000	cny
CY2021	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-1911000	cny
CY2022	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	42770000	cny
CY2023	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2230000	cny
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	328839000	cny
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-247439000	cny
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	128447000	cny
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	38545000	cny
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	367384000	cny
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	119945000	cny
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	367384000	cny
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	119945000	cny
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	248392000	cny
CY2021Q4	us-gaap	Restricted Cash RestrictedCash	5000000	cny
CY2022Q4	us-gaap	Restricted Cash RestrictedCash	5000000	cny
CY2023Q4	us-gaap	Restricted Cash RestrictedCash	5000000	cny
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	362384000	cny
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	114945000	cny
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	243392000	cny
CY2021	us-gaap	Interest Paid Net InterestPaidNet	10537000	cny
CY2022	us-gaap	Interest Paid Net InterestPaidNet	2581000	cny
CY2023	us-gaap	Interest Paid Net InterestPaidNet	898000	cny
CY2021	us-gaap	Income Taxes Paid IncomeTaxesPaid	3000	cny
CY2022	us-gaap	Income Taxes Paid IncomeTaxesPaid	4000	cny
CY2023	us-gaap	Income Taxes Paid IncomeTaxesPaid	162000	cny
CY2021	ccg	Accretions To Preferred Shares Redemption Value AccretionsToPreferredSharesRedemptionValue	-101467000	cny
CY2022	ccg	Accretions To Preferred Shares Redemption Value AccretionsToPreferredSharesRedemptionValue	188271000	cny
CY2023	ccg	Accretions To Preferred Shares Redemption Value AccretionsToPreferredSharesRedemptionValue	762169000	cny
CY2023	us-gaap	Conversion Of Stock Amount Converted1 ConversionOfStockAmountConverted1	2321050000	cny
CY2021	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	16305000	cny
CY2022	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	8787000	cny
CY2023	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	5602000	cny
CY2021	ccg	Redesignation From Ordinary Shares To Pre A Convertible Redeemable Preferred Shares RedesignationFromOrdinarySharesToPreAConvertibleRedeemablePreferredShares	165468000	cny
CY2023	ccg	Cash Held By Prime Impact And Cash Related To Prime Impact Trust Account CashHeldByPrimeImpactAndCashRelatedToPrimeImpactTrustAccount	360745000	cny
CY2023	ccg	Redemptions Redemptions	-331574000	cny
CY2023	ccg	Cash Related To Trust Account Net Of Redemptions CashRelatedToTrustAccountNetOfRedemptions	29171000	cny
CY2023	ccg	Cash Consideration For The Subscription Of Shares By The Sponsor CashConsiderationForTheSubscriptionOfSharesByTheSponsor	14787000	cny
CY2023	ccg	Payment Of Costs PaymentOfCosts	43958000	cny
CY2023	ccg	Cash Paid Associated With Transaction Costs Allocated To Reverse Recapitalization CashPaidAssociatedWithTransactionCostsAllocatedToReverseRecapitalization	-33031000	cny
CY2023	ccg	Professional Expenses ProfessionalExpenses	-2318000	cny
CY2023	ccg	Proceeds From Pipe Financing Prime Impact Cayman Llc ProceedsFromPIPEFinancingPrimeImpactCaymanLLC	8609000	cny
CY2023	ccg	Proceeds From Pipe Financing World Dynamic Limited ProceedsFromPIPEFinancingWorldDynamicLimited	93436000	cny
CY2023	ccg	Proceeds From Pipe Financing Goldrock Holdings Limited ProceedsFromPIPEFinancingGoldrockHoldingsLimited	35863000	cny
CY2023	ccg	Total Contributions From Pipe Financing TotalContributionsFromPIPEFinancing	137908000	cny
CY2023	ccg	Cash Payment Associated With Transaction Costs Allocated To Pipe CashPaymentAssociatedWithTransactionCostsAllocatedToPIPE	-4953000	cny
CY2023	ccg	Net Contributions From Reverse Recapitalization And Pipe Financing NetContributionsFromReverseRecapitalizationAndPIPEFinancing	132955000	cny
CY2023	ccg	Beneficial Interests Percentage BeneficialInterestsPercentage	1	pure
CY2023	us-gaap	Variable Interest Entity Ownership Percentage VariableInterestEntityOwnershipPercentage	1	pure
CY2023	ccg	Percentage Of Equity Interests PercentageOfEquityInterests	0.1424	pure
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-146500000	cny
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-91000000	cny
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-159600000	cny
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-187600000	cny
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-158900000	cny
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-27000000	cny
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-1259500000	cny
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-2113800000	cny
CY2023Q3	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	19200000	usd
CY2023Q3	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	137900000	cny
CY2023	us-gaap	Prior Period Reclassification Adjustment PriorPeriodReclassificationAdjustment	600000	usd
CY2022	us-gaap	Prior Period Reclassification Adjustment PriorPeriodReclassificationAdjustment	2100000	usd
CY2023	us-gaap	Use Of Estimates UseOfEstimates	<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><b>c)</b></td><td style="text-align: justify"><b>Use of estimates</b></td> </tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: left; text-indent: 0.25in">The preparation of the Group’s consolidated financial statements in conformity with the U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent liabilities at the balance sheet date and reported revenues and expenses during the reported periods in the consolidated financial statements and accompanying notes. Significant accounting estimates include, but are not limited to, provision of current expected credit losses of receivables, fair value of amounts due to related party, ordinary shares and preferred shares and warrant, as well as the valuation and recognition of share-based compensation expenses. Actual results could differ from those estimates, and as such, differences may be material to the consolidated financial statements.</p>
CY2022Q4	us-gaap	Cash And Due From Banks CashAndDueFromBanks	11500000	usd
CY2022Q4	us-gaap	Cash And Due From Banks CashAndDueFromBanks	80100000	cny
CY2023Q4	us-gaap	Cash And Due From Banks CashAndDueFromBanks	18200000	usd
CY2023Q4	us-gaap	Cash And Due From Banks CashAndDueFromBanks	129300000	cny
CY2022Q4	ccg	Cast At Bank Denominate CastAtBankDenominate	34800000	usd
CY2023Q4	ccg	Cast At Bank Denominate CastAtBankDenominate	114100000	cny
CY2022Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	113900000	cny
CY2023Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	124400000	cny
CY2022Q4	us-gaap	Derivative Variable Interest Rate DerivativeVariableInterestRate	0.991	pure
CY2023Q4	us-gaap	Derivative Variable Interest Rate DerivativeVariableInterestRate	0.511	pure
CY2022Q4	us-gaap	Restricted Cash RestrictedCash	5000000	cny
CY2023Q4	us-gaap	Restricted Cash RestrictedCash	5000000	cny
CY2022Q4	us-gaap	Deposits Deposits	34800000	cny
CY2023Q4	us-gaap	Deposits Deposits	21500000	cny
CY2021	us-gaap	Interest Income Other InterestIncomeOther	100000	cny
CY2022	us-gaap	Interest Income Other InterestIncomeOther	80000.00	cny
CY2023	us-gaap	Interest Income Other InterestIncomeOther	160000	cny
CY2021	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	500000	cny
CY2022	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	20000.00	cny
CY2023	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	1200000	cny
CY2022Q4	us-gaap	Goodwill Goodwill	84600000	cny
CY2023Q4	us-gaap	Goodwill Goodwill	84600000	cny
CY2021	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	3300000	cny
CY2022	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	8700000	cny
CY2023	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	900000	cny
CY2020Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	3300000	cny
CY2021Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	8700000	cny
CY2022Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	900000	cny
CY2023Q4	us-gaap	Accrued Employee Benefits Current And Noncurrent AccruedEmployeeBenefitsCurrentAndNoncurrent	56200000	cny
CY2021Q4	us-gaap	Grants Receivable GrantsReceivable	1100000	cny
CY2022Q4	us-gaap	Grants Receivable GrantsReceivable	1400000	cny
CY2023Q4	us-gaap	Grants Receivable GrantsReceivable	1400000	cny
CY2021Q4	ccg	Unamortized Portion Of Deferred Government Grants UnamortizedPortionOfDeferredGovernmentGrants	800000	cny
CY2022Q4	ccg	Unamortized Portion Of Deferred Government Grants UnamortizedPortionOfDeferredGovernmentGrants	300000	cny
CY2022Q4	us-gaap	Accrued Employee Benefits Current And Noncurrent AccruedEmployeeBenefitsCurrentAndNoncurrent	48600000	cny
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Tax Settlements Foreign EffectiveIncomeTaxRateReconciliationTaxSettlementsForeign	0.50	pure
CY2023	ccg	Statutory Surplus Of Registered Capital Of Entity StatutorySurplusOfRegisteredCapitalOfEntity	0.50	pure
CY2023	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left"><b>cc)</b></td><td style="text-align: justify"><b>Concentration and risk</b></td> </tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0.25in"><i>Foreign currency exchange rate risk</i></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: left; text-indent: 0.25in">The Group’s operating transactions are mainly denominated in RMB. RMB is not freely convertible into foreign currencies. The value of the RMB is subject to changes by the central government policies and to international economic and political developments. In the PRC, certain foreign exchange transactions are required by law to be transacted only through authorized financial institutions at exchange rates set by the People’s Bank of China (the “PBOC”). Remittances in currencies other than RMB by the Group in the PRC must be processed through PBOC or other PRC foreign exchange regulatory bodies which require certain supporting documents in order to effect the remittances. As of December 31, 2022 and 2023, the Group’s cash and cash equivalents, and restricted cash denominated in RMB were RMB39.8 million and RMB119.1 million, accounting for 33.2% and 47.9% of the Group’s total cash, cash equivalents and restricted cash, respectively.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0.25in"><i>Credit risk and concentration risk</i></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: left; text-indent: 0.25in">Financial instruments that potentially subject the Group to the concentration of credit risk consist of cash and cash equivalents, restricted cash and accounts receivable. As of December 31, 2022 and 2023, the Group’s cash and cash equivalents, and restricted cash were typically unsecured and highly concentrated in a few major financial institutions located in China, which management consider being of high credit quality and continually monitors the creditworthiness of these financial institutions. Accounts receivable is typically unsecured and is generally derived from revenue earned from the Company’s insurance transaction services business.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0.25in"><i>Concentration of customers and suppliers</i></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: left; text-indent: 0.25in">There was <span style="-sec-ix-hidden: hidden-fact-150">nil</span>, <span style="-sec-ix-hidden: hidden-fact-151">nil</span> and <span style="-sec-ix-hidden: hidden-fact-152">nil</span> customer which individually accounted for 10% or more of the Group’s total operating revenue for the years ended December 31, 2021, 2022 and 2023.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: left; text-indent: 0.25in">There was <span style="-sec-ix-hidden: hidden-fact-153">nil</span>, <span style="-sec-ix-hidden: hidden-fact-154">nil</span> and <span style="-sec-ix-hidden: hidden-fact-155">nil</span> supplier which individually accounted for more than 10% of the Group’s total costs and expenses for the years ended December 31, 2021, 2022 and 2023.</p>
CY2022Q4	us-gaap	Cash Cash Equivalents And Short Term Investments CashCashEquivalentsAndShortTermInvestments	39800000	cny
CY2023Q4	us-gaap	Restricted Cash Equivalents RestrictedCashEquivalents	119100000	cny
CY2022	ccg	Percentage Of Cash Equivalents And Restricted Cash PercentageOfCashEquivalentsAndRestrictedCash	0.332	pure
CY2023	ccg	Percentage Of Cash Equivalents And Restricted Cash PercentageOfCashEquivalentsAndRestrictedCash	0.479	pure
CY2023Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	455818627	shares
CY2023Q4	ccg	Common Shares Issued And Outstanding CommonSharesIssuedAndOutstanding	676533464	shares
CY2023Q4	us-gaap	Preferred Stock Convertible Shares Issuable PreferredStockConvertibleSharesIssuable	253181563	shares
CY2023Q4	ccg	Ordinary Shares Issued And Outstanding OrdinarySharesIssuedAndOutstanding	253181563	shares
CY2023Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	865227	shares
CY2023Q3	us-gaap	Shares Issued SharesIssued	5000000	shares
CY2023Q4	ccg	Shares Outstanding To Reverse Recapitalization SharesOutstandingToReverseRecapitalization	450615461	usd
CY2023	us-gaap	Conversion Of Stock Shares Issued1 ConversionOfStockSharesIssued1	73004981	shares
CY2023	ccg	Reverse Recapitalizationand Pipe Transactions ReverseRecapitalizationandPIPETransactions	75439209	shares
CY2022Q4	us-gaap	Accounts Receivable Gross AccountsReceivableGross	402694000	cny
CY2023Q4	us-gaap	Accounts Receivable Gross AccountsReceivableGross	468296000	cny
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	1027000	cny
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	2230000	cny
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	401667000	cny
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	466066000	cny
CY2021Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	1004000	cny
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	1027000	cny
CY2022	ccg	Allowance For Doubtful Accounts Receivable Additions AllowanceForDoubtfulAccountsReceivableAdditions	23000	cny
CY2023	ccg	Allowance For Doubtful Accounts Receivable Additions AllowanceForDoubtfulAccountsReceivableAdditions	1203000	cny
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	1027000	cny
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	2230000	cny
CY2022Q4	us-gaap	Value Added Tax Receivable Current ValueAddedTaxReceivableCurrent	34215000	cny
CY2023Q4	us-gaap	Value Added Tax Receivable Current ValueAddedTaxReceivableCurrent	39914000	cny
CY2022Q4	ccg	Service Fees ServiceFees	4057000	cny
CY2023Q4	ccg	Service Fees ServiceFees	4504000	cny
CY2022Q4	us-gaap	Prepaid Rent PrepaidRent	2603000	cny
CY2023Q4	us-gaap	Prepaid Rent PrepaidRent	2449000	cny
CY2022Q4	ccg	Prepaid Staff Advance PrepaidStaffAdvance	1292000	cny
CY2023Q4	ccg	Prepaid Staff Advance PrepaidStaffAdvance	230000	cny
CY2022Q4	ccg	Prepaid Rental Expense For Other Leases PrepaidRentalExpenseForOtherLeases	695000	cny
CY2023Q4	ccg	Prepaid Rental Expense For Other Leases PrepaidRentalExpenseForOtherLeases	630000	cny
CY2022Q4	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	1550000	cny
CY2023Q4	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	1594000	cny
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	44412000	cny
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	49321000	cny
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	2100000	cny
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	9253000	cny
CY2023Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	9445000	cny
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	7082000	cny
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	7778000	cny
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2171000	cny
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1667000	cny
CY2021	us-gaap	Depreciation Depreciation	1700000	cny
CY2022	us-gaap	Depreciation Depreciation	1200000	cny
CY2023	us-gaap	Depreciation Depreciation	1000000	cny
CY2022Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	58916000	cny
CY2023Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	58916000	cny
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	10150000	cny
CY2023Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	8050000	cny
CY2021	us-gaap	Adjustment For Amortization AdjustmentForAmortization	2200000	cny
CY2022	us-gaap	Adjustment For Amortization AdjustmentForAmortization	2100000	cny
CY2023	us-gaap	Adjustment For Amortization AdjustmentForAmortization	2100000	cny
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	2100000	cny
CY2021	us-gaap	Operating Lease Cost OperatingLeaseCost	11984000	cny
CY2022	us-gaap	Operating Lease Cost OperatingLeaseCost	9013000	cny
CY2023	us-gaap	Operating Lease Cost OperatingLeaseCost	8880000	cny
CY2021	us-gaap	Short Term Lease Cost ShortTermLeaseCost	1317000	cny
CY2022	us-gaap	Short Term Lease Cost ShortTermLeaseCost	1949000	cny
CY2023	us-gaap	Short Term Lease Cost ShortTermLeaseCost	1194000	cny
CY2021	us-gaap	Lease Cost LeaseCost	13301000	cny
CY2022	us-gaap	Lease Cost LeaseCost	10962000	cny
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	2100000	cny
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	1750000	cny
CY2023Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	8050000	cny
CY2022Q4	us-gaap	Goodwill Gross GoodwillGross	84609000	cny
CY2023Q4	us-gaap	Goodwill Gross GoodwillGross	84609000	cny
CY2022Q4	us-gaap	Goodwill Goodwill	84609000	cny
CY2023Q4	us-gaap	Goodwill Goodwill	84609000	cny
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	14723000	cny
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	10249000	cny
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	7676000	cny
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	3951000	cny
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	6226000	cny
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	5398000	cny
CY2022Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	13902000	cny
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	9349000	cny
CY2021Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P3Y5M12D
CY2022Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P2Y6M7D
CY2023Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P3Y7D
CY2021Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0524	pure
CY2022Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0408	pure
CY2023Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0391	pure
CY2023	us-gaap	Lease Cost LeaseCost	10074000	cny
CY2021	us-gaap	Operating Lease Payments OperatingLeasePayments	11512000	cny
CY2022	us-gaap	Operating Lease Payments OperatingLeasePayments	5065000	cny
CY2023	us-gaap	Operating Lease Payments OperatingLeasePayments	8984000	cny
CY2021	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	16305000	cny
CY2022	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	8787000	cny
CY2023	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	5602000	cny
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	4261000	cny
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	2867000	cny
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	1325000	cny
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	1432000	cny
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	9885000	cny
CY2023Q4	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	536000	cny
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	9349000	cny
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	3951000	cny
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	5398000	cny
CY2023Q4	us-gaap	Short Term Borrowings ShortTermBorrowings	20000000	cny
CY2023Q4	us-gaap	Short Term Borrowings ShortTermBorrowings	20000000	cny
CY2023Q4	us-gaap	Other Short Term Borrowings OtherShortTermBorrowings	10000000	cny
CY2022Q2	us-gaap	Line Of Credit Facility Annual Principal Payment LineOfCreditFacilityAnnualPrincipalPayment	10000000	cny
CY2022Q1	us-gaap	Line Of Credit Facility Annual Principal Payment LineOfCreditFacilityAnnualPrincipalPayment	3000000	cny
CY2022Q2	us-gaap	Line Of Credit Facility Annual Principal Payment LineOfCreditFacilityAnnualPrincipalPayment	4000000	cny
CY2022Q2	us-gaap	Line Of Credit Facility Annual Principal Payment LineOfCreditFacilityAnnualPrincipalPayment	3000000	cny
CY2023Q2	us-gaap	Line Of Credit Facility Annual Principal Payment LineOfCreditFacilityAnnualPrincipalPayment	10000000	cny
CY2023	us-gaap	Line Of Credit Facility Expiration Date1 LineOfCreditFacilityExpirationDate1	2025-06-13
CY2023Q2	us-gaap	Line Of Credit Facility Annual Principal Payment LineOfCreditFacilityAnnualPrincipalPayment	6000000	cny
CY2023Q2	us-gaap	Line Of Credit Facility Annual Principal Payment LineOfCreditFacilityAnnualPrincipalPayment	50000000	cny
CY2023Q4	us-gaap	Short Term Bank Loans And Notes Payable ShortTermBankLoansAndNotesPayable	20000000	cny
CY2023	us-gaap	Short Term Debt Interest Rate Increase ShortTermDebtInterestRateIncrease	0.12	pure
CY2021Q1	us-gaap	Short Term Investments ShortTermInvestments	10000000	cny
CY2021Q2	us-gaap	Short Term Investments ShortTermInvestments	10000000	cny
CY2021	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	-3651000	cny
CY2018Q2	us-gaap	Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential	0.165	pure
CY2018Q2	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.0825	pure
CY2018Q2	ccg	Income Tax Assessable Profit IncomeTaxAssessableProfit	2000000	hkd
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential	0.165	pure
CY2023	ccg	Income Tax Assessable Profit IncomeTaxAssessableProfit	2	usd
CY2023	ccg	Preferential Tax Rate PreferentialTaxRate	0.15	pure
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-132584000	cny
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-74843000	cny
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-149818000	cny
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	-14399000	cny
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	-16700000	cny
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	-10135000	cny
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-146983000	cny
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-91543000	cny
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-159953000	cny
CY2021	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	525000	cny
CY2022	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	525000	cny
CY2023	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	525000	cny
CY2021	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-525000	cny
CY2022	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-525000	cny
CY2023	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-525000	cny
CY2021	us-gaap	Income Taxes Paid IncomeTaxesPaid	3000	cny
CY2022	us-gaap	Income Taxes Paid IncomeTaxesPaid	4000	cny
CY2023	us-gaap	Income Taxes Paid IncomeTaxesPaid	162000	cny
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-522000	cny
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-521000	cny
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-363000	cny
CY2021	us-gaap	Income Loss Attributable To Parent IncomeLossAttributableToParent	-146983000	cny
CY2022	us-gaap	Income Loss Attributable To Parent IncomeLossAttributableToParent	-91543000	cny
CY2023	us-gaap	Income Loss Attributable To Parent IncomeLossAttributableToParent	-159953000	cny
CY2021	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.25	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.25	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.25	pure
CY2021	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-36746000	cny
CY2022	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-22886000	cny
CY2023	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-39989000	cny
CY2022	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	241000	cny
CY2023	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	18589000	cny
CY2023	us-gaap	Income Tax Reconciliation Change In Enacted Tax Rate IncomeTaxReconciliationChangeInEnactedTaxRate	8158000	cny
CY2023	ccg	Expired Operating Loss ExpiredOperatingLoss	-14966000	cny
CY2021	ccg	Permanent Differences PermanentDifferences	-931000	cny
CY2022	ccg	Permanent Differences PermanentDifferences	-2822000	cny
CY2023	ccg	Permanent Differences PermanentDifferences	13722000	cny
CY2021	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	40806000	cny
CY2022	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	24946000	cny
CY2023	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	-15809000	cny
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-522000	cny
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-521000	cny
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-363000	cny
CY2023Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	610880	cny
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	140950000	cny
CY2023Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	124740000	cny
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities	7570000	cny
CY2023Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities	9480000	cny
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Other DeferredTaxAssetsTaxDeferredExpenseOther	9841000	cny
CY2023Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Other DeferredTaxAssetsTaxDeferredExpenseOther	6500000	cny
CY2022Q4	ccg	Fair Value Changes Of Amounts Due To Related Party FairValueChangesOfAmountsDueToRelatedParty	3108000	cny
CY2023Q4	ccg	Fair Value Changes Of Amounts Due To Related Party FairValueChangesOfAmountsDueToRelatedParty	4237000	cny
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Other DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther	400000	cny
CY2023Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Other DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther	427000	cny
CY2022Q4	us-gaap	Deferred Revenue DeferredRevenue	358000	cny
CY2023Q4	us-gaap	Deferred Revenue DeferredRevenue	358000	cny
CY2022Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	1006000	cny
CY2023Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	1682000	cny
CY2022Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	163233000	cny
CY2023Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	147424000	cny
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	163233000	cny
CY2023Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	147424000	cny
CY2022Q4	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets	2538000	cny
CY2023Q4	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets	2013000	cny
CY2022Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	2538000	cny
CY2023Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	2013000	cny
CY2020Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	97481000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	138287000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	163233000	usd
CY2021	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	-40806000	usd
CY2022	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	-24946000	usd
CY2023	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	15809000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	138287000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	163233000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	147424000	usd
CY2023Q4	us-gaap	Percentage Of Lifo Inventory PercentageOfLIFOInventory	0.10	pure
CY2022Q4	us-gaap	Contract With Customer Refund Liability ContractWithCustomerRefundLiability	6632000	cny
CY2023Q4	us-gaap	Contract With Customer Refund Liability ContractWithCustomerRefundLiability	7703000	cny
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	544000	cny
CY2023	ccg	Value Added Tax Rate ValueAddedTaxRate	0.06	pure
CY2022Q4	us-gaap	Sales And Excise Tax Payable Current SalesAndExciseTaxPayableCurrent	2088000	cny
CY2023Q4	us-gaap	Sales And Excise Tax Payable Current SalesAndExciseTaxPayableCurrent	43000	cny
CY2022Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	815000	cny
CY2023Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	770000	cny
CY2022Q4	ccg	Stamp Duty Payables StampDutyPayables	66000	cny
CY2022Q4	us-gaap	Construction Payable Current ConstructionPayableCurrent	25000	cny
CY2023Q4	us-gaap	Construction Payable Current ConstructionPayableCurrent	52000	cny
CY2022Q4	ccg	Educational Development Payables EducationalDevelopmentPayables	50000	cny
CY2023Q4	ccg	Educational Development Payables EducationalDevelopmentPayables	37000	cny
CY2022Q4	us-gaap	Accounts Payable Other Current AccountsPayableOtherCurrent	34000	cny
CY2023Q4	us-gaap	Accounts Payable Other Current AccountsPayableOtherCurrent	48000	cny
CY2022Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	3078000	cny
CY2023Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	950000	cny
CY2022Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	31899000	cny
CY2023Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	16490000	cny
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	789000	cny
CY2022Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	1813000	cny
CY2023	ccg	Total Number Of Shares Transfer Preferred Shares To Ordinary Shareholders TotalNumberOfSharesTransferPreferredSharesToOrdinaryShareholders	-35190468	shares
CY2023Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	777000	cny
CY2022Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	40888000	cny
CY2023Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	25759000	cny
CY2021Q4	us-gaap	Other Borrowings OtherBorrowings	3000000	usd
CY2021Q4	us-gaap	Investment Interest Rate InvestmentInterestRate	0.095	pure
CY2021Q4	us-gaap	Other Long Term Debt OtherLongTermDebt	19100000	cny
CY2021Q2	us-gaap	Sale Of Stock Consideration Received On Transaction SaleOfStockConsiderationReceivedOnTransaction	15000000	usd
CY2022Q1	ccg	Implied Valuation Of Shares ImpliedValuationOfShares	800000000	usd
CY2022Q1	ccg	Percentage Of Ordinary Shares PercentageOfOrdinaryShares	0.10	pure
CY2021Q2	us-gaap	Sale Of Stock Number Of Shares Issued In Transaction SaleOfStockNumberOfSharesIssuedInTransaction	260667	shares
CY2023	ccg	Percent Of Qipo Offering Price PercentOfQIPOOfferingPrice	0.75	pure
CY2023	ccg	Compound Interest Rate Of Capital Contribution CompoundInterestRateOfCapitalContribution	0.10	pure
CY2021	us-gaap	Preferred Stock Accretion Of Redemption Discount PreferredStockAccretionOfRedemptionDiscount	101500000	cny
CY2022	us-gaap	Preferred Stock Accretion Of Redemption Discount PreferredStockAccretionOfRedemptionDiscount	188300000	cny
	us-gaap	Preferred Stock Accretion Of Redemption Discount PreferredStockAccretionOfRedemptionDiscount	762200000	cny
CY2020Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	19242444	shares
CY2021	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	13546219	shares
CY2021	ccg	Shares Redesignation From Ordinary Shares To Series Pre A Preferred Sharein SharesRedesignationFromOrdinarySharesToSeriesPreAPreferredSharein	4429111	shares
CY2021Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	37217774	shares
CY2020Q4	us-gaap	Preferred Stock Value Outstanding PreferredStockValueOutstanding	785891000	cny
CY2021	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	653247000	cny
CY2021	us-gaap	Temporary Equity Accretion To Redemption Value Adjustment TemporaryEquityAccretionToRedemptionValueAdjustment	-101467000	cny
CY2021	us-gaap	Reclassifications Of Temporary To Permanent Equity ReclassificationsOfTemporaryToPermanentEquity	165468000	cny
CY2021Q4	us-gaap	Preferred Stock Value Outstanding PreferredStockValueOutstanding	1503139000	cny
CY2021Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	37217774	shares
CY2022	ccg	Shares Redemption Of Preferred Shares SharesRedemptionOfPreferredShares	-2027306	shares
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	35190468	shares
CY2021Q4	us-gaap	Preferred Stock Value Outstanding PreferredStockValueOutstanding	1503139000	cny
CY2022	us-gaap	Temporary Equity Accretion To Redemption Value Adjustment TemporaryEquityAccretionToRedemptionValueAdjustment	188271000	cny
CY2022	ccg	Total Amount Redemption Of Preferred Shares TotalAmountRedemptionOfPreferredShares	-132529000	cny
CY2022Q4	us-gaap	Preferred Stock Value Outstanding PreferredStockValueOutstanding	1558881000	cny
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	35190468	shares
CY2022Q4	us-gaap	Preferred Stock Value Outstanding PreferredStockValueOutstanding	1558881000	cny
CY2022	us-gaap	Depreciation And Amortization DepreciationAndAmortization	2391000	cny
CY2023	us-gaap	Depreciation And Amortization DepreciationAndAmortization	2100000	cny
CY2021	us-gaap	Salaries Wages And Officers Compensation SalariesWagesAndOfficersCompensation	2074000	cny
CY2022	us-gaap	Salaries Wages And Officers Compensation SalariesWagesAndOfficersCompensation	2070000	cny
CY2023	us-gaap	Salaries Wages And Officers Compensation SalariesWagesAndOfficersCompensation	7790000	cny
CY2021	ccg	Cloud Service Fees CloudServiceFees	1764000	cny
CY2022	ccg	Cloud Service Fees CloudServiceFees	1838000	cny
CY2023	us-gaap	Temporary Equity Accretion To Redemption Value Adjustment TemporaryEquityAccretionToRedemptionValueAdjustment	762169000	cny
CY2023	us-gaap	Temporary Equity Other Changes TemporaryEquityOtherChanges	-2321050000	cny
CY2023	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1	pure
CY2021	us-gaap	Revenues Revenues	1735404000	cny
CY2022	us-gaap	Revenues Revenues	2679059000	cny
CY2023	us-gaap	Revenues Revenues	3301418000	cny
CY2021	ccg	Cost Of Referral Partners CostOfReferralPartners	1581153000	cny
CY2022	ccg	Cost Of Referral Partners CostOfReferralPartners	2424579000	cny
CY2023	ccg	Cost Of Referral Partners CostOfReferralPartners	3017871000	cny
CY2021	ccg	Service Fee Paid To Thirdparty Payment Platforms ServiceFeePaidToThirdpartyPaymentPlatforms	62019000	cny
CY2022	ccg	Service Fee Paid To Thirdparty Payment Platforms ServiceFeePaidToThirdpartyPaymentPlatforms	104627000	cny
CY2023	ccg	Service Fee Paid To Thirdparty Payment Platforms ServiceFeePaidToThirdpartyPaymentPlatforms	129453000	cny
CY2021	ccg	Customer Service Costs CustomerServiceCosts	4428000	cny
CY2021	us-gaap	Depreciation And Amortization DepreciationAndAmortization	2119000	cny
CY2023	ccg	Cloud Service Fees CloudServiceFees	1525000	cny
CY2021	us-gaap	Taxes Other TaxesOther	1035000	cny
CY2022	us-gaap	Taxes Other TaxesOther	1241000	cny
CY2023	us-gaap	Taxes Other TaxesOther	2454000	cny
CY2021	us-gaap	Cost Of Revenue CostOfRevenue	1654592000	cny
CY2022	us-gaap	Cost Of Revenue CostOfRevenue	2536746000	cny
CY2023	us-gaap	Cost Of Revenue CostOfRevenue	3161193000	cny
CY2021	us-gaap	Pension Contributions PensionContributions	17143000	cny
CY2022	us-gaap	Pension Contributions PensionContributions	20842000	cny
CY2023	us-gaap	Pension Contributions PensionContributions	21095000	cny
CY2021	us-gaap	Other Postretirement Benefits Payments OtherPostretirementBenefitsPayments	5857000	cny
CY2022	us-gaap	Other Postretirement Benefits Payments OtherPostretirementBenefitsPayments	7227000	cny
CY2023	us-gaap	Other Postretirement Benefits Payments OtherPostretirementBenefitsPayments	6726000	cny
CY2021	us-gaap	Pension And Other Postretirement Benefit Contributions PensionAndOtherPostretirementBenefitContributions	23000000	cny
CY2022	us-gaap	Pension And Other Postretirement Benefit Contributions PensionAndOtherPostretirementBenefitContributions	28069000	cny
CY2023	us-gaap	Pension And Other Postretirement Benefit Contributions PensionAndOtherPostretirementBenefitContributions	27821000	cny
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0166	pure
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0388	pure
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.642	pure
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P10Y
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P10Y
CY2023	ccg	Maturities Term MaturitiesTerm	P10Y
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	8893000	shares
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	2.0163
CY2020	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P6Y9M3D
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	65574000	cny
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	547000	shares
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	8.0748
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	1433000	shares
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	5.3355
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	8007000	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	1.8362
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P5Y8M8D
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	65574000	cny
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	8007000	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice	1.8362
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P5Y8M8D
CY2021Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	65574000	cny
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	8007000	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	1.8362
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P5Y8M8D
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	65574000	cny
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	58000	shares
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	8.0885
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	7949000	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	1.7905
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P4Y8M1D
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	65572000	cny
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	7949000	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice	1.7905
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P4Y8M1D
CY2022Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	65572000	cny
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	7949000	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	1.7905
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P4Y8M1D
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	65572000	cny
CY2023	ccg	Share Based Compensation Arrangement By Share Based Payment Award Options Employees Replacement ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsEmployeesReplacement	-7876000	shares
CY2023	ccg	Share Based Compensation Arrangements By Share Based Payment Award Options Replacement In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsReplacementInPeriodWeightedAverageExercisePrice	1.3119	shares
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	528000	shares
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0.1
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	28000	shares
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	8.1954
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	573000	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.6675
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P9Y8M23D
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	23775000	cny
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	295000	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice	1.1978
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P9Y5M23D
CY2023Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	11367000	cny
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue	5.3151
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue	0.7801
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue	5.2688
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue	0.7733
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue	42.1761
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue	5.9404
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-146461000	cny
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-91022000	cny
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-159590000	cny
CY2021	us-gaap	Temporary Equity Accretion To Redemption Value Adjustment TemporaryEquityAccretionToRedemptionValueAdjustment	-101467000	cny
CY2022	us-gaap	Temporary Equity Accretion To Redemption Value Adjustment TemporaryEquityAccretionToRedemptionValueAdjustment	188271000	cny
CY2023	us-gaap	Temporary Equity Accretion To Redemption Value Adjustment TemporaryEquityAccretionToRedemptionValueAdjustment	762169000	cny
CY2021	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-44994000	cny
CY2022	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-279293000	cny
CY2023	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-921759000	cny
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	33831133	shares
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	31780394	shares
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	45415205	shares
CY2021	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	33831133	shares
CY2022	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	31780394	shares
CY2023	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	45415205	shares
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.33
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-8.79
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-20.3
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.33
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-8.79
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-20.3
CY2021	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	28672636	shares
CY2022	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	35185538	shares
CY2023	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	24777946	shares
CY2021	us-gaap	Weighted Average Number Of Shares Restricted Stock WeightedAverageNumberOfSharesRestrictedStock	941263	shares
CY2022	us-gaap	Weighted Average Number Of Shares Restricted Stock WeightedAverageNumberOfSharesRestrictedStock	1032167	shares
CY2023	us-gaap	Weighted Average Number Of Shares Restricted Stock WeightedAverageNumberOfSharesRestrictedStock	523097	shares
CY2021	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	8202538	shares
CY2022	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	7975942	shares
CY2023	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	822952	shares
CY2022Q4	us-gaap	Operating Leases Future Minimum Payments Receivable Thereafter OperatingLeasesFutureMinimumPaymentsReceivableThereafter	2000000	cny
CY2023Q4	us-gaap	Operating Leases Future Minimum Payments Receivable Thereafter OperatingLeasesFutureMinimumPaymentsReceivableThereafter	1000000	cny
CY2023Q4	us-gaap	Lessee Operating Lease Term Of Contract LesseeOperatingLeaseTermOfContract	P1Y
CY2022Q4	us-gaap	Other Liabilities OtherLiabilities	59932000	cny
CY2023Q4	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	6269000	cny
CY2023Q4	us-gaap	Other Liabilities OtherLiabilities	55251000	cny
CY2020Q4	us-gaap	Line Of Credit Facility Periodic Payment Principal LineOfCreditFacilityPeriodicPaymentPrincipal	10000000	cny
CY2021Q1	us-gaap	Line Of Credit Facility Annual Principal Payment LineOfCreditFacilityAnnualPrincipalPayment	65000000	cny
CY2021Q1	us-gaap	Line Of Credit Facility Interest Rate During Period LineOfCreditFacilityInterestRateDuringPeriod	0.10	pure
CY2020Q4	us-gaap	Convertible Debt ConvertibleDebt	55000000	cny
CY2021	us-gaap	Fair Value Option Changes In Fair Value Gain Loss1 FairValueOptionChangesInFairValueGainLoss1	-11200000	cny
CY2022	us-gaap	Fair Value Option Changes In Fair Value Gain Loss1 FairValueOptionChangesInFairValueGainLoss1	-6500000	cny
CY2023	us-gaap	Fair Value Option Changes In Fair Value Gain Loss1 FairValueOptionChangesInFairValueGainLoss1	-7500000	cny
CY2021	us-gaap	Fair Value Net Derivative Asset Liability Measured On Recurring Basis Change In Unrealized Gain Loss FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisChangeInUnrealizedGainLoss	1600000	cny
CY2022	us-gaap	Fair Value Net Derivative Asset Liability Measured On Recurring Basis Change In Unrealized Gain Loss FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisChangeInUnrealizedGainLoss	-500000	cny
CY2023	us-gaap	Fair Value Net Derivative Asset Liability Measured On Recurring Basis Change In Unrealized Gain Loss FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisChangeInUnrealizedGainLoss	-400000	cny
CY2021	ccg	Fairvalue Of Corporate Borrowings Discount Rate FairvalueOfCorporateBorrowingsDiscountRate	0.1501	pure
CY2022	ccg	Fairvalue Of Corporate Borrowings Discount Rate FairvalueOfCorporateBorrowingsDiscountRate	0.127	pure
CY2023	ccg	Fairvalue Of Corporate Borrowings Discount Rate FairvalueOfCorporateBorrowingsDiscountRate	0.1187	pure
CY2020Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue	56353000	cny
CY2021	us-gaap	Market Risk Benefit Change In Fair Value Gain Loss MarketRiskBenefitChangeInFairValueGainLoss	-11242000	cny
CY2021	us-gaap	Change In Unrealized Gain Loss On Hedged Item In Fair Value Hedge1 ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1	-1590000	cny
CY2021	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	13000000	cny
CY2021Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue	53005000	cny
CY2021Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue	53005000	cny
CY2022	us-gaap	Market Risk Benefit Change In Fair Value Gain Loss MarketRiskBenefitChangeInFairValueGainLoss	-6451000	cny
CY2022	us-gaap	Change In Unrealized Gain Loss On Hedged Item In Fair Value Hedge1 ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1	476000	cny
CY2022Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue	59932000	cny
CY2022Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue	59932000	cny
CY2023	us-gaap	Market Risk Benefit Change In Fair Value Gain Loss MarketRiskBenefitChangeInFairValueGainLoss	-7524000	cny
CY2023	us-gaap	Change In Unrealized Gain Loss On Hedged Item In Fair Value Hedge1 ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1	405000	cny
CY2023	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	12610000	cny
CY2023Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue	55251000	cny
CY2022Q4	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	1045000	cny
CY2023Q4	us-gaap	Percentage Of Unamortized Film Costs PercentageOfUnamortizedFilmCosts	0.10	pure
CY2023Q4	us-gaap	Restricted Cash And Investments RestrictedCashAndInvestments	328500000	cny
CY2023Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent		cny
CY2022Q4	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent		cny
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent		cny
CY2022Q4	us-gaap	Short Term Borrowings ShortTermBorrowings		cny
CY2022Q4	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent		cny
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		cny
CY2023Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		cny
CY2023Q4	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent		cny
CY2023	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues		cny
CY2023	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue		cny
CY2022	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment		cny
CY2021	us-gaap	Proceeds From Maturities Prepayments And Calls Of Shortterm Investments ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments		cny
CY2023	us-gaap	Repayments Of Other Short Term Debt RepaymentsOfOtherShortTermDebt		cny
CY2022	us-gaap	Proceeds From Repayments Of Related Party Debt ProceedsFromRepaymentsOfRelatedPartyDebt		cny
CY2023	us-gaap	Proceeds From Repayments Of Related Party Debt ProceedsFromRepaymentsOfRelatedPartyDebt		cny
CY2022	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt		cny
CY2023	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt		cny
CY2023	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt		cny
CY2022	ccg	Cash Repayments Of Amounts Due To A Related Party CashRepaymentsOfAmountsDueToARelatedParty		cny
CY2023	ccg	Cash Repayments Of Amounts Due To A Related Party CashRepaymentsOfAmountsDueToARelatedParty		cny
CY2022	ccg	Cash Repayments Of Amounts Due To A Related Party Note20aii CashRepaymentsOfAmountsDueToARelatedPartyNote20aii		cny
CY2021	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts		cny
CY2022	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts		cny
CY2022	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt		cny
CY2023	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt		cny
CY2022	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock		cny
CY2023	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock		cny
CY2021	us-gaap	Proceeds From Issuance Of Preferred Stock And Preference Stock ProceedsFromIssuanceOfPreferredStockAndPreferenceStock		cny
CY2023	us-gaap	Proceeds From Issuance Of Preferred Stock And Preference Stock ProceedsFromIssuanceOfPreferredStockAndPreferenceStock		cny
CY2022	ccg	Redesignation From Ordinary Shares To Pre A Convertible Redeemable Preferred Shares RedesignationFromOrdinarySharesToPreAConvertibleRedeemablePreferredShares		cny
CY2023	ccg	Redesignation From Ordinary Shares To Pre A Convertible Redeemable Preferred Shares RedesignationFromOrdinarySharesToPreAConvertibleRedeemablePreferredShares		cny
CY2022	us-gaap	Statutory Accounting Practices Statutory Net Income Amount StatutoryAccountingPracticesStatutoryNetIncomeAmount		usd
CY2023	us-gaap	Statutory Accounting Practices Statutory Net Income Amount StatutoryAccountingPracticesStatutoryNetIncomeAmount		usd
CY2023Q4	ccg	Unamortized Portion Of Deferred Government Grants UnamortizedPortionOfDeferredGovernmentGrants		cny
CY2022	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs		cny
CY2023	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs		cny
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive		cny
CY2022Q4	us-gaap	Goodwill Impaired Accumulated Impairment Loss GoodwillImpairedAccumulatedImpairmentLoss		cny
CY2023Q4	us-gaap	Goodwill Impaired Accumulated Impairment Loss GoodwillImpairedAccumulatedImpairmentLoss		cny
CY2022Q4	us-gaap	Short Term Borrowings ShortTermBorrowings		cny
CY2022Q4	us-gaap	Short Term Borrowings ShortTermBorrowings		cny
CY2021	us-gaap	Income Tax Reconciliation Change In Enacted Tax Rate IncomeTaxReconciliationChangeInEnactedTaxRate		cny
CY2022	us-gaap	Income Tax Reconciliation Change In Enacted Tax Rate IncomeTaxReconciliationChangeInEnactedTaxRate		cny
CY2021	ccg	Expired Operating Loss ExpiredOperatingLoss		cny
CY2022	ccg	Expired Operating Loss ExpiredOperatingLoss		cny
CY2022Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet		cny
CY2023Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet		cny
CY2023Q4	ccg	Stamp Duty Payables StampDutyPayables		cny
CY2022Q4	us-gaap	Accounts Payable Other Current And Noncurrent AccountsPayableOtherCurrentAndNoncurrent		cny
CY2023Q4	us-gaap	Accounts Payable Other Current And Noncurrent AccountsPayableOtherCurrentAndNoncurrent		cny
CY2023Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding		shares
CY2023Q4	us-gaap	Preferred Stock Value Outstanding PreferredStockValueOutstanding		cny
CY2022	ccg	Customer Service Costs CustomerServiceCosts		cny
CY2023	ccg	Customer Service Costs CustomerServiceCosts		cny
CY2022Q4	us-gaap	Option Contract Indexed To Equity Settlement Share Fair Value Per Share OptionContractIndexedToEquitySettlementShareFairValuePerShare
CY2022	ccg	Discount Rate After Tax DiscountRateAfterTax		pure
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate		pure
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate		pure
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Discount For Postvesting Restrictions ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsDiscountForPostvestingRestrictions		pure
CY2021	ccg	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Life Granted SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualLifeGranted
CY2021	ccg	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Aggregated Intrinsic Value Granted ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAggregatedIntrinsicValueGranted		cny
CY2021	ccg	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Life Forfeited SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualLifeForfeited
CY2021	ccg	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Aggregated Intrinsic Value Forfeited ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAggregatedIntrinsicValueForfeited		cny
CY2022	ccg	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Life Forfeited SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualLifeForfeited
CY2022	ccg	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Aggregated Intrinsic Value Forfeited ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAggregatedIntrinsicValueForfeited		cny
CY2023	ccg	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Life Replacement SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualLifeReplacement
CY2023	ccg	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Aggregated Intrinsic Value Replacement ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAggregatedIntrinsicValueReplacement		cny
CY2023	ccg	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Life Granted SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualLifeGranted
CY2023	ccg	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Aggregated Intrinsic Value Granted ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAggregatedIntrinsicValueGranted		cny
CY2023	ccg	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Life Forfeited SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualLifeForfeited
CY2023	ccg	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Aggregated Intrinsic Value Forfeited ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAggregatedIntrinsicValueForfeited		cny
CY2023	dei	Amendment Flag AmendmentFlag	false
CY2023	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2023	dei	Entity Central Index Key EntityCentralIndexKey	0001965473

Files In Submission

Name	View Source	Status
0001213900-24-037229-index-headers.html	Edgar Link	pending
0001213900-24-037229-index.html	Edgar Link	pending
0001213900-24-037229.txt	Edgar Link	pending
0001213900-24-037229-xbrl.zip	Edgar Link	pending
ccg-20231231.xsd	Edgar Link	pending
ea0204149-20f_cheche.htm	Edgar Link	pending
ea020414901ex11-1_cheche.htm	Edgar Link	pending
ea020414901ex12-1_cheche.htm	Edgar Link	pending
ea020414901ex12-2_cheche.htm	Edgar Link	pending
ea020414901ex13-1_cheche.htm	Edgar Link	pending
ea020414901ex13-2_cheche.htm	Edgar Link	pending
ea020414901ex15-1_cheche.htm	Edgar Link	pending
ea020414901ex15-2_cheche.htm	Edgar Link	pending
ea020414901ex2-1_cheche.htm	Edgar Link	pending
ea020414901ex97-1_cheche.htm	Edgar Link	pending
ex15-2_001.jpg	Edgar Link	pending
ex15-2_002.jpg	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
image_001.jpg	Edgar Link	pending
image_002.jpg	Edgar Link	pending
image_003.jpg	Edgar Link	pending
image_004.jpg	Edgar Link	pending
image_005.jpg	Edgar Link	pending
image_006.jpg	Edgar Link	pending
image_007.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R100.htm	Edgar Link	pending
R101.htm	Edgar Link	pending
R102.htm	Edgar Link	pending
R103.htm	Edgar Link	pending
R104.htm	Edgar Link	pending
R105.htm	Edgar Link	pending
R106.htm	Edgar Link	pending
R107.htm	Edgar Link	pending
ccg-20231231_def.xml	Edgar Link	unprocessable
ccg-20231231_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
ea0204149-20f_cheche_htm.xml	Edgar Link	completed
R108.htm	Edgar Link	pending
R109.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R110.htm	Edgar Link	pending
R111.htm	Edgar Link	pending
R112.htm	Edgar Link	pending
R113.htm	Edgar Link	pending
R114.htm	Edgar Link	pending
R115.htm	Edgar Link	pending
R116.htm	Edgar Link	pending
R117.htm	Edgar Link	pending
R118.htm	Edgar Link	pending
R119.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R87.htm	Edgar Link	pending
R88.htm	Edgar Link	pending
R89.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R90.htm	Edgar Link	pending
R91.htm	Edgar Link	pending
R92.htm	Edgar Link	pending
R93.htm	Edgar Link	pending
R94.htm	Edgar Link	pending
R95.htm	Edgar Link	pending
R96.htm	Edgar Link	pending
R97.htm	Edgar Link	pending
R98.htm	Edgar Link	pending
R99.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
ccg-20231231_cal.xml	Edgar Link	unprocessable
ccg-20231231_lab.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$CCG
Cheche Group Inc. Stock $ccg

2023 Q4 Form 20-F Financial Statement

#000121390024037229 Filed on April 29, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CCG Cheche Group Inc. Stock $ccg

2023 Q4 Form 20-F Financial Statement

#000121390024037229 Filed on April 29, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CCG
Cheche Group Inc. Stock $ccg